Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited scores highest on Nitro (99) and lowest on Price (11). Its PosiPenta is 43.46 out of 100, around the middle of similar companies.
On the Penta Grid this week, Bafna Pharmaceuticals Limited is Grid #116 of 168 in the Healthcare sector in India, and Grid #1,602 of 2,356 in India.
Compared with similar companies in the Healthcare sector in India.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Bafna Pharmaceuticals Limited | 43.46 | 11 | 24 | 99 | 27 | 57 |
| Bajaj HealthCare Limited | 40.53 | 62 | 41 | 25 | 18 | 56 |
| Lincoln Pharmaceuticals Limited | 62.17 | 95 | 80 | 26 | 70 | 40 |
| GPT Healthcare Limited | 56.47 | 66 | 53 | 44 | 54 | 64 |
| Sigachi Industries Limited | 32.19 | 68 | 13 | 30 | 27 | 23 |
| 3B Blackbio Dx Limited | 66.69 | 71 | 87 | 55 | 80 | 40 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 140.23 |
| P/B ratio | 11.35 |
EEarnings
| Trailing EPS | ₹3.29 |
| Forward EPS | — |
NNitro
| Price | 461.35 |
| 52-week high | 461.35 |
| 52-week low | 94.77 |
| Fall from 52-week high | 0.0% |
TTorque
| Return on equity (ROE) (calculated) | 8.09% |
| Debt-to-equity | 0.39 |
AAnchor
| Beta (price swings) | 0.07 |
| Market cap | ₹1,091 Cr |
| Promoter holding | 75.00% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Bafna Pharmaceuticals Limited's PosiPenta score?
Bafna Pharmaceuticals Limited's PosiPenta is 43.46 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Bafna Pharmaceuticals Limited stand on the Penta Grid?
On the Penta Grid this week, Bafna Pharmaceuticals Limited is Grid #116 of 168 in the Healthcare sector in India, and Grid #1,602 of 2,356 in India.
Which PosiPenta pillar is strongest for Bafna Pharmaceuticals Limited?
Nitro (momentum), with a score of 99 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Bafna Pharmaceuticals Limited?
Price (valuation), with a score of 11 out of 100: much weaker than most similar companies.
Has Bafna Pharmaceuticals Limited's PosiPenta changed since last week?
Yes, it fell 3.50 points, from 46.96 to 43.46.
PositoAI is for research and education only and is not investment advice.